Release Today Neuren Valuation Estimate Raised, page-66

Just thought I would touch base to see how things are panning out .

I hope the deal comes out as it will really be massive if it works but as someone who runs phase 3 trials I just hope investors are clear about the risks.

The reality is, and I am not sugar coating it or being biased, or being super negative, the fact is that the majority of phase 3 trials fail. Start-up companies are having to go it alone to do the phase 3 trials so they can be bought out.

To illustrate, Pfizer recently completely killed their neuroscience R&D after too many of their pipeline drugs failed in late stage trials

I wish you all the best, most importantly for the wonderful Rett and developmental disorders community. If this drug is a success you have every right to blow the trumpet and make some serious money.

I haven;t yet seen data that gets me excited though, but I cant wait to oneday see it.   

The reason why I post here is a friend of mine came to me with some pretty hyped up statements about this company from some spruikers. I dont like people not being informed about risks and hyped up statements from investment spruikers. DYOR.